Table 5.
Comparison between patients undergoing surgery at < 14 and > 14 days following PTGBD
| Factors | ≤ 14-day group (n = 10) | ≥ 15-day group (n = 12) P | P |
|---|---|---|---|
| Gender (Male), n (%) | 9 (64.3) | 5 (62.5) | 0.9333 |
| Age (years) | 75.4 ± 2.7 | 77.5 ± 3.5 | 0.6324 |
| Comorbidity (Yes), n (%) | 10 (71.4) | 8 (100.0) | 0.0426 |
| Anticoagulant medication (Yes), n (%) | 2 (14.3) | 0 (0.0) | 0.1658 |
| ASA status | 2.36 ± 0.18 | 2.38 ± 0.24 | 0.9529 |
| Cholecystitis grade | 1.9 ± 0.2 | 1.5 ± 0.2 | 0.2092 |
| WBC before PTBGD (/mL) | 13,141 ± 1800 | 14,402 ± 2382 | 0.6771 |
| CRP before PTGBD (mg/dL) | 18.19 ± 2.85 | 14.80 ± 3.77 | 0.4807 |
| WBC before surgery (/mL) | 10,191 ± 1492 | 7198 ± 1973 | 0.2404 |
| CRP before surgery (mg/dL) | 11.13 ± 2.00 | 0.99 ± 2.64 | 0.0007 |
| Surgical complications (Yes), n (%) | 1 (7.1) | 1 (12.5) | 0.6795 |
| Operating time (min) | 117.4 ± 10.6 | 128.5 ± 14.1 | 0.5345 |
| Blood loss (g) | 176.1 ± 63.8 | 116.1 ± 84.4 | 0.5772 |
| Adhesion grade | 1.6 ± 0.2 | 1.9 ± 0.3 | 0.5082 |
| Laparotomy conversion (Yes), n (%) | 5 (35.7) | 2 (25.0) | 0.5999 |
| Hospitalization after surgery (days) | 12.8 ± 4.9 | 25.9 ± 6.5 | 0.1259 |
| Total hospitalization (days) | 19.5 ± 7.2 | 59.9 ± 9.5 | 0.0060 |
Bold values indicate significant differences
Data are presented as mean ± standard deviation unless otherwise indicated
≤ 14-day group: patients with an interval between PTGBD and surgery ≤ 14 days, ≥ 15-day group: patients with an interval between PTGBD and surgery ≥ 15 days, PTGBD: percutaneous transhepatic gallbladder drainage, WBC: white blood cell, CRP: C-reactive protein, ASA: American Society of Anesthesiologists